Nexgel

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The company was founded on January 13, 2009 and is headquartered in Langhorne, PA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nexgel reports record revenue in Q2 2024, anticipates strong growth

Nexgel's Q2 2024 performance reflects robust revenue growth driven by strategic acquisitions and expansion efforts.
Despite short-term challenges in capacity expansion, the company's financial outlook remains positive with strong revenue guidance.
Opportunities from new partnerships and product launches position Nexgel for continued growth and market success.

Nexgel reports record Q3 earnings, eyes growth through strategic initiatives

Nexgel's Q3 2024 showcased robust financial performance with record revenue and improved margins.
Strategic acquisitions, partnerships, and growth initiatives position Nexgel for continued success.
While challenges like sustaining growth and managing costs exist, opportunities for expansion and profitability are promising.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The company was founded on January 13, 2009 and is headquartered in Langhorne, PA.

NEXGEL, Inc. (NASDAQ:NXGL ) Q2 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Valter Pinto - MD, KCSA Strategic Communications Adam Levy - CEO Adam Drapczuk - CFO Operator Good afternoon, I will be your conference operator today. At this time, I would like to welcome everyone to NEXGEL Incorporated's Second Quarter 2023 Earnings Conference Call.

NEXGEL, Inc. (NXGL) Q2 2023 Earnings Call Transcript

Nexgel Inc has announced its financial results, revealing record second-quarter revenue.  “Record second-quarter revenue of $1.17 million, an increase of 108% year-over-year, exceeded our projections,” CEO Adam Levy said in a statement.

Nexgel posts record 2Q revenue on contract manufacturing surge

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

NEXGEL (NASDAQ:NXGL) has announced a partnership with Engima Health for marketing services and to distribute its hydrogel products in retail stores across North America. A new joint venture (JV) company, Enigma Health will also be providing services for Moiety, a topical lotions and cream manufacturer, NEXGEL (NASDAQ:NXGL) said.

NEXGEL announces retail distribution partnership with Enigma Health

LANGHORNE, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced a new strategic relationship with Enigma Health, a new joint venture company, for retail distribution and marketing services in North America. In addition to NEXGEL, Enigma will also be providing services for Moiety, Inc., a cutting edge topical lotion and creams manufacturer.

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

LANGHORNE, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Levy, CEO, will participate in a virtual fireside chat with Naz Rahman, CFA, Vice President, Senior Equity Research Analyst, at the Maxim Group Virtual Healthcare Conference being held on June 20th - 22nd.

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

LANGHORNE, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Levy, CEO, will participate in the LD Micro Invitational XIII being held on June 6th – 8th in Los Angeles.

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

NEXGEL (NASDAQ:NXGL), a leading provider of hydrogel products, reported a 56.6% year-over-year increase in revenue over the first quarter of 2023. Total revenue for the three-month period to end March 31 came in at $620,000 driven by sales growth in contract manufacturing and branded consumer products.

NEXGEL reports impressive revenue growth in 1Q, expects $1M revenue in 2Q

Management will host a conference call at 4:30 P . M . ET on the same day

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

NEXGEL (NASDAQ:NXGL) Inc has announced that it fiscal 2022 revenue rose 32% year over year to $2.05 million, which the company attributed primarily to an increase in contract manufacturing and branded consumer products. The provider of ultra-gentle, high-water-content hydrogels also realized a 3,100% improvement in its gross profit margin for the year to approximately 12.5%, which NEXGEL (NASDAQ:NXGL) anticipates will continue to improve due to both increased revenue against fixed facility expenses and larger production runs on commercially-proven products.

NEXGEL sees FY22 revenue surge 32% on rise in contract manufacturing and branded consumer products

2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

NEXGEL (NASDAQ:NXGL) Inc has announced a partnership with former Major League Lacrosse (MLL) player and founder of The Face-off Academy, Greg “The Beast” Gurenlian, to provide athletes with Turfguard, the company's unique hydrogel dressing. NEXGEL (NASDAQ:NXGL)'s Turfguard is a patch designed to treat turf burns and protect athletic wounds.

NEXGEL teams up with former lacrosse pro Greg 'The Beast' Gurenlian to bring Turfguard patches to players

LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today it has partnered with former Major League Lacrosse (MLL) player and founder of The Face-off Academy, Greg “The Beast” Gurenlian, to provide athletes with a better treatment for turf burn through the use of NEXGEL's Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds.

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

NEXGEL (NASDAQ:NXGL) has dealt into in a new joint venture with CG Laboratories Inc, one of its largest customers, in a converting and packaging business. The producer of high-water-content hydrogel products has had a business relationship with CG Labs, a medical devices and services company, for over 15 years and the newly constructed 50:50 joint venture company CG Converting and Packaging LLC is expected to benefit from new opportunities and synergies.

NEXGEL strikes partnership with CG Labs to seize strategic opportunities

LANGHORNE, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today the acquisition of 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business. The agreement is effective March 1, 2023.

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

NEXGEL Inc (NASDAQ:NXGL) has announced the appointment of Scott Henry as a new independent director to the company's board effective immediately, he will also serve as a member of the board's Audit Committee. Henry is a managing director and senior research analyst at ROTH Capital Partners with 20 years of sell-side coverage in the pharmaceutical, biotechnology and medical device sectors.

NEXGEL announces appointment of Scott Henry, managing director at ROTH Capital Partners, as a new independent director to its board

LANGHORNE, Pa. , Jan. 17, 2023 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today the appointment of Scott Henry, CFA as a new independent director to the Company's Board of Directors (the "Board"), effective immediately.

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

NEXGEL (NASDAQ:NXGL) Inc said it has launched a unique hydrogel dressing, called Turfguard, for treating painful turf burns and protecting sports-related wounds.  “For athletes, turf burns and skin abrasions are often a common, unfortunate part of the game,” said Adam Levy, chief executive officer of NEXGEL in a statement.

NEXGEL launches new hydrogel dressing to treat turf burns and protect athletic wounds

LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc . (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that it has launched a new product dubbed Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds. Turfguard's sterile silver patches, cleared by the U.S. Food and Drug Administration, kill 99 percent of staph, MRSA and strep.

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

LANGHORNE, Pa. , Dec. 7, 2022 /PRNewswire/ -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that its Board of Directors has approved a share repurchase program, effective immediately, with authorization to purchase up to $500,000 of the Company's common shares.

NEXGEL Announces Share Repurchase Program

LANGHORNE, Pa. , Dec. 1, 2022 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today it will host a virtual fireside chat with its Chief Executive Officer, Adam Levy, on Wednesday, December 14, 2022 at 11:00 a.m. ET.

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET

NEXGEL (NASDAQ:NXGL), the leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, has announced its results for the third quarter to September 30, 2022, which revealed strong revenue growth and an improvement in the gross margin.  Revenue for the period was $568,000, an increase of 69.6% on the corresponding period in 2021, driven by sales growth in branded consumer products, the company said.

NEXGEL says Q3 revenue jumps almost 70%

Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26%

News for Nexgel Stock (NXGL)